MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers-Reference-Cited by-同舟云学术

MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers

Published:2018-07-25 Issue:1 Volume:15 Page:
ISSN:1542-6416
Container-title:Clinical Proteomics
language:en
Short-container-title:Clin Proteom

Author:

Padoan Andrea,Basso Daniela,Zambon Carlo-Federico,Prayer-Galetti Tommaso,Arrigoni Giorgio,Bozzato Dania,Moz Stefania,Zattoni Filiberto,Bellocco Rino,Plebani Mario

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Clinical Biochemistry,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12014-018-9199-8.pdf

Reference32 articles.

1. Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67:1099–109.

2. Martin SA, Haren MT, Marshall VR, Lange K, Wittert GA. Members of the florey adelaide male ageing study. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2011;29:179–84.

3. Zambon C-F, Basso D, Prayer-Galetti T, Navaglia F, Fasolo M, Fogar P, et al. Quantitative PSA mRNA determination in blood: a biochemical tool for scoring localized prostate cancer. Clin Biochem. 2006;39:333–8.

4. Guess HA. Benign prostatic hyperplasia and prostate cancer. Epidemiol Rev. 2001;23:152–8.

5. Chevli KK, Duff M, Walter P, Yu C, Capuder B, Elshafei A, et al. Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy. J Urol. 2014;191:1743–8.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in mass spectrometry-based urinary proteomics;Clinical Proteomics;2024-02-22

2. MALDI-TOF MS: A Promising Analytical Approach to Cancer Diagnostics and Monitoring;Separations;2023-08-14

3. Urinary endogenous peptides as biomarkers for prostate cancer;Oncology Letters;2023-03-14

4. Utilizing MALDI-TOF MS and LC-MS/MS to access serum peptidome-based biomarkers in canine oral tumors;Scientific Reports;2022-12-14

5. Evaluation of the reliability of MS1‐based approach to profile naturally occurring peptides with clinical relevance in urine samples;Rapid Communications in Mass Spectrometry;2022-08-22